今开:1.74 | 昨收:1.74 |
最高:1.83 | 最低:1.65 |
涨停价:0.0 | 跌停价:0.0 |
总市值:8.0261471E7 |
Cue Biopharma(CUE)03-29 04:35
$Cue Biopharma(CUE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038084 Act: 33 Size: 146 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028609 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)04-27 04:05
$Cue Biopharma(CUE)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-049072 Act: 34 Size: 1 MB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028612 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028608 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-12 06:45
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000025 Act: 34 Size: 41 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:45
$Cue Biopharma(CUE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038059 Act: 34 Size: 12 MB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028611 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028613 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)05-10 04:05
$Cue Biopharma(CUE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-056838 Act: 34 Size: 7 MB 网页链接查看全文
$Cue生物制药(CUE)$ 内部交易: 2020-09-29,Director,Gray Cameron ,买入,5000普通股, $15.00
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-026662 Size: 6 KB 网页链接
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-051145 Size: 5 KB 网页链接
$Cue生物制药(CUE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-051142 Size: 6 KB 网页链接
$Cue生物制药(CUE)$ 8-K Current report, item 5.02 Accession Number: 0001193125-20-247622 Act: 34 Size: 145 KB 网页链接
$Cue生物制药(CUE)$ 内部交易: 2020-08-21,CFO,Millar Kerri-Ann ,期权,6666普通股, $0.00
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-048212 Size: 13 KB 网页链接
$Cue生物制药(CUE)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001193125-20-228378 Act: 34 Size: 246 KB 网页链接
$Cue生物制药(CUE)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-045921 Size: 9 KB 网页链接
$Cue生物制药(CUE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-038375 Act: 34 Size: 7 MB 网页链接